DILATREND
|
Siegfried
|
carvedilol |
Antianginoso Antihipertensivo |
12.5 mg comp.ran.x 28 | $14.409,00 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.206,44 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $8.844,72 AF $5.564,28 |
|
|
|
|
12.5 mg comp.ran.x 30 | $14.841,27 | (25/04/25) |
PAMI |
|
AF $4.394,12 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $9.097,50 AF $5.743,77 |
|
|
|
|
12.5 mg comp.ran.x 56 | $23.536,65 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $5.856,64 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.142,54 AF $8.394,11 |
|
|
|
|
25 mg comp.ran.x 28 | $18.347,81 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.951,90 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.217,77 AF $7.130,04 |
|
|
|
|
25 mg comp.ran.x 30 | $18.347,51 | (25/04/25) |
PAMI |
|
AF $5.128,82 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.235,45 AF $7.112,06 |
|
|
|
|
25 mg comp.ran.x 56 | $30.874,75 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $7.443,69 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $19.121,41 AF $11.753,34 |
|
|
|
|
3.125 mg comp.ran.x 28 | $6.321,56 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $1.804,16 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $4.203,90 AF $2.117,66 |
|
|
|
|
3.125 mg comp.ran.x 30 | $6.319,91 | (25/04/25) |
PAMI |
|
AF $1.866,27 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $4.162,87 AF $2.157,04 |
|
|
|
|
50 mg comp.ran.x 28 | $23.779,42 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $6.470,82 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $15.352,21 AF $8.427,21 |
|
|
|
|
6.25 mg comp.ran.x 28 | $11.999,93 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $3.283,81 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $7.334,32 AF $4.665,61 |
|
|
|
|
6.25 mg comp.ran.x 30 | $12.001,12 | (25/04/25) |
PAMI |
|
AF $3.408,10 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $7.226,66 AF $4.774,46 |
|
|
|
|
6.25 mg comp.ran.x 56 | $18.560,55 | (25/04/25) |
SIFAR |
Producto Reconocido |
|
PAMI |
|
AF $4.306,51 |
|
|
IOMA |
Cobertura Monto Fijo |
OS $11.193,12 AF $7.367,43 |
|
|
|
|
|